| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 151, Issue 4 1802-1810, Copyright © 1993 by American Association of Immunologists
ARTICLES |
RA Franklin, B Mazer, H Sawami, GB Mills, N Terada, JJ Lucas and EW Gelfand
Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.
Platelet activating factor (PAF), a phospholipid mediator produced by a variety of cell types, has potent biological activities in many cellular systems. We report that stimulation of B cell lines with PAF induced tyrosine phosphorylation of a protein, approximately 42 kDa in size. The PAF receptor antagonist WEB 2086 as well as the structural analogue PAF antagonist CV3988 inhibited the response, demonstrating that the tyrosine phosphorylation was attributable to PAF binding to a specific receptor. Immunoblot analysis, using an antibody to microtubule-associated protein-2 kinase, demonstrated the presence of a single protein species in unstimulated cells. PAF treatment induced the appearance of an additional species with a slightly reduced mobility in the gel. This PAF-inducible band had the same mobility on SDS-PAGE gels as the protein that was tyrosine-phosphorylated after PAF stimulation. Tyrosine phosphorylation of the 42-kDa protein was rapid, detectable within 30 s, and evident over a wide range of PAF concentrations (10(- 7) to 10(-10) M). Treatment of cells with phorbol myristate acetate induced tyrosine phosphorylation of a protein with the same mobility in SDS-PAGE gels as the protein induced after PAF stimulation. Lysates from PAF-stimulated lymphoblastoid cells exhibited more than twice the ability to phosphorylate myelin basic protein than lysates from untreated cells. In addition, the ribosomal S6 peptide kinase activity (S6PK) was increased after PAF stimulation of the B cells. Taken together, the results suggest that PAF stimulation of B cells induces the tyrosine phosphorylation and activation of microtubule-associated protein-2 kinase.
This article has been cited by other articles:
|
|
 |
|
  S. L. Brown, V. R. Jala, S. K. Raghuwanshi, M. W. Nasser, B. Haribabu, and R. M. Richardson Activation and regulation of platelet-activating factor receptor: role of gi and gq in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals. J. Immunol., September 1, 2006; 177(5): 3242 - 3249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Deo, T. W. Axelrad, E. G. Robert, V. Marcheselli, N. G. Bazan, and J. D. Hunt Phosphorylation of STAT-3 in Response to Basic Fibroblast Growth Factor Occurs through a Mechanism Involving Platelet-activating Factor, JAK-2, and Src in Human Umbilical Vein Endothelial Cells. EVIDENCE FOR A DUAL KINASE MECHANISM J. Biol. Chem., June 7, 2002; 277(24): 21237 - 21245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Dupre, C. Le Gouill, M. Rola-Pleszczynski, and J. Stankova Inverse Agonist Activity of Selected Ligands of Platelet-Activating Factor Receptor J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 358 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Zhuang, Y. Bastien, and B. D. Mazer Activation Via Multiple Signaling Pathways Induces Down-Regulation of Platelet-Activating Factor Receptors on Human B Lymphocytes J. Immunol., September 1, 2000; 165(5): 2423 - 2431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Merendino, M. B. Dwinell, N. Varki, L. Eckmann, and M. F. Kagnoff Human intestinal epithelial cells express receptors for platelet-activating factor Am J Physiol Gastrointest Liver Physiol, October 1, 1999; 277(4): G810 - G818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Bastien, B. J. Toledano, N. Mehio, L. Cameron, B. Lamoukhaid, P. Renzi, Q. Hamid, and B. D. Mazer Detection of Functional Platelet-Activating Factor Receptors on Human Tonsillar B Lymphocytes J. Immunol., May 1, 1999; 162(9): 5498 - 5505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Rosskopf, W. Daelman, S. Busch, M. Schurks, K. Hartung, A. Kribben, M. C. Michel, and W. Siffert Growth factor-like action of lysophosphatidic acid on human B lymphoblasts Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1573 - C1582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Deehan, M. J. Frame, R. M. E. Parkhouse, S. D. Seatter, S. D. Reid, M. M. Harnett, and W. Harnett A Phosphorylcholine-Containing Filarial Nematode-Secreted Product Disrupts B Lymphocyte Activation by Targeting Key Proliferative Signaling Pathways J. Immunol., March 15, 1998; 160(6): 2692 - 2699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen and S. N. Giri J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1047 - 1058. [Abstract] [Full Text]
|
|
|
|
|
|
J.-L. Parent, C. L. Gouill, E. Escher, and M. Rola-Pleszczynski Identification of Transmembrane Domain Residues Determinant in the Structure-Function Relationship of the Human Platelet-activating Factor Receptor by Site-directed Mutagenesis J. Biol. Chem., September 20, 1996; 271(38): 23298 - 23303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Ferby, I. Waga, M. Hoshino, K. Kume, and T. Shimizu Wortmannin Inhibits Mitogen-activated Protein Kinase Activation by Platelet-activating Factor through a Mechanism Independent of p85/p110-type Phosphatidylinositol 3-Kinase J. Biol. Chem., May 17, 1996; 271(20): 11684 - 11688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Parent, C. Le Gouill, A. J. de Brum-Fernandes, M. Rola-Pleszczynski, and J. Stanková Mutations of Two Adjacent Amino Acids Generate Inactive and Constitutively Active Forms of the Human Platelet-activating Factor Receptor J. Biol. Chem., April 5, 1996; 271(14): 7949 - 7955. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
